133 related articles for article (PubMed ID: 10195397)
1. Finasteride is the main inhibitor of 5alpha-reductase activity in microdissected dermal papillae of human hair follicles.
Hoffmann R; Happle R
Arch Dermatol Res; 1999; 291(2-3):100-3. PubMed ID: 10195397
[No Abstract] [Full Text] [Related]
2. Comparative study of human steroid 5alpha-reductase isoforms in prostate and female breast skin tissues: sensitivity to inhibition by finasteride and epristeride.
Ranjan M; Diffley P; Stephen G; Price D; Walton TJ; Newton RP
Life Sci; 2002 May; 71(2):115-26. PubMed ID: 12031682
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor.
Yao Z; Xu Y; Zhang M; Jiang S; Nicklaus MC; Liao C
Bioorg Med Chem Lett; 2011 Jan; 21(1):475-8. PubMed ID: 21094046
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat.
Stuart JD; Lee FW; Simpson Noel D; Kadwell SH; Overton LK; Hoffman CR; Kost TA; Tippin TK; Yeager RL; Batchelor KW; Bramson HN
Biochem Pharmacol; 2001 Oct; 62(7):933-42. PubMed ID: 11543729
[TBL] [Abstract][Full Text] [Related]
5. Effect of a novel steroid (PM-9) on the inhibition of 5alpha-reductase present in Penicillium crustosum broths.
Flores E; Cabeza M; Quiroz A; Bratoeff E; García G; Ramírez E
Steroids; 2003 Mar; 68(3):271-5. PubMed ID: 12628690
[TBL] [Abstract][Full Text] [Related]
6. Type-1 steroid 5 alpha-reductase is functionally active in the hair follicle as evidenced by new selective inhibitors of either type-1 or type-2 human steroid 5 alpha-reductase.
Gerst C; Dalko M; Pichaud P; Galey JB; Buan B; Bernard BA
Exp Dermatol; 2002 Feb; 11(1):52-8. PubMed ID: 11962492
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
Gao W; Kearbey JD; Nair VA; Chung K; Parlow AF; Miller DD; Dalton JT
Endocrinology; 2004 Dec; 145(12):5420-8. PubMed ID: 15308613
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of rat alpha-reductases by finasteride: evidence for isozyme differences in the mechanism of inhibition.
Azzolina B; Ellsworth K; Andersson S; Geissler W; Bull HG; Harris GS
J Steroid Biochem Mol Biol; 1997 Apr; 61(1-2):55-64. PubMed ID: 9328210
[TBL] [Abstract][Full Text] [Related]
9. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Bartsch G; Rittmaster RS; Klocker H
Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
[TBL] [Abstract][Full Text] [Related]
10. Plasma androsterone/epiandrosterone sulfates as markers of 5 alpha-reductase activity: effect of finasteride in normal men.
Lewis JG; George PM; Elder PA
Steroids; 1997; 62(8-9):632-5. PubMed ID: 9292937
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the 5alpha-reductase-3alpha-hydroxysteroid dehydrogenase complex in the human brain.
Steckelbroeck S; Watzka M; Reichelt R; Hans VH; Stoffel-Wagner B; Heidrich DD; Schramm J; Bidlingmaier F; Klingmüller D
J Clin Endocrinol Metab; 2001 Mar; 86(3):1324-31. PubMed ID: 11238528
[TBL] [Abstract][Full Text] [Related]
12. Finasteride inhibits the progesterone-induced spike-wave discharges in a genetic model of absence epilepsy.
van Luijtelaar G; Budziszewska B; Tetich M; Lasoń W
Pharmacol Biochem Behav; 2003 Jul; 75(4):889-94. PubMed ID: 12957232
[TBL] [Abstract][Full Text] [Related]
13. Finasteride.
Chaudhary UB; Turner JS
Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):873-81. PubMed ID: 20536414
[TBL] [Abstract][Full Text] [Related]
14. Age-related changes in brain and pituitary 5 alpha-reductase with finasteride (Proscar) treatment.
Lephart ED
Neurobiol Aging; 1995; 16(4):647-50. PubMed ID: 8544916
[TBL] [Abstract][Full Text] [Related]
15. Determination of rat 5alpha-reductase type 1 isozyme activity and its inhibition by novel steroidal oxazolines.
Szécsi M; Ondré D; Tóth I; Magony S; Wölfling J; Schneider G; Julesz J
Acta Biol Hung; 2010 Sep; 61(3):274-81. PubMed ID: 20724274
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological and clinical profile of finasteride (PROPECIA)].
Fukuzumi H; Ikeda T; Narita H; Takubo T; Matsuda T; Taniguchi T
Nihon Yakurigaku Zasshi; 2006 Jun; 127(6):495-502. PubMed ID: 16880702
[No Abstract] [Full Text] [Related]
17. Hypothalamic aromatase cytochrome P450 and 5alpha-reductase enzyme activities in pregnant and female rats.
Ladle DR; Jacobson NA; Lephart ED
Life Sci; 1997; 61(20):2017-26. PubMed ID: 9366509
[TBL] [Abstract][Full Text] [Related]
18. The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating.
Frau R; Mosher LJ; Bini V; Pillolla G; Pes R; Saba P; Fanni S; Devoto P; Bortolato M
Psychoneuroendocrinology; 2016 Jan; 63():59-67. PubMed ID: 26415119
[TBL] [Abstract][Full Text] [Related]
19. Effect of finasteride on behavioural arousal and somatosensory evoked potentials in fetal sheep.
Nicol MB; Hirst JJ; Walker DW
Neurosci Lett; 2001 Jun; 306(1-2):13-6. PubMed ID: 11403946
[TBL] [Abstract][Full Text] [Related]
20. CGP 53153: a new potent inhibitor of 5alpha-reductase.
Häusler A; Allegrini PR; Biollaz M; Batzl C; Scheidegger E; Bhatnagar AS
J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):187-95. PubMed ID: 8645628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
